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ㅋ
Microbial recognition by multicellular organisms is initially accomplished by a group of pattern recognition receptors which are 
specialized to recognize microbe-associated molecular patterns (MAMPs) such as lipopolysaccharide, bacterial lipoprotein, CpG 
DNA motif, double strand RNA and flagellin. Toll-like receptors (TLRs) are the representative pattern recognition receptors, and 
microbial recognition by TLRs elicits innate and inflammatory responses. Ten TLR family members have been presently identified 
in human genome, and numerous studies discovered that intracellular responses from MAMPs-TLR engagements are mediated 
by a participation of at least 4 immediate adaptor molecules such as myeloid differentiation primary response gene-88 
(MyD88), MyD88 adaptor-like (Mal) (also known as Toll/IL-1 receptor domain-containing adaptor protein [TIRAP]), Toll/IL-1 
receptor domain-containing adaptor-inducing interferon-β (TRIF) and TRIF-related adaptor molecule (TRAM) leading to activate 
transcription factors including nuclear factor κB, activator protein-1 and interferon-regulatory factors. Given that large amounts 
of commensal microbiota constantly reside in the intestinal lumen, enteric microbial recognition by TLRs at the intestinal epi-
thelium provides a critical impact on regulating intestinal homeostasis. Indeed, aberrant TLR4 and TLR5 activations are etiolog-
ically associated with the development and progress of intestinal inflammatory diseases including inflammatory bowel dis-
ease and necrotizing enterocolitis. In this review article, we present the molecular mechanism by which TLRs elicit intracellular 
signal transduction, and summarize the physiological relevance of TLRs related to the gastrointestinal tract.
(J Neurogastroenterol Motil 2011;17:28-34)
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Introduction
In the human gastrointestinal tract, there are up to 1×10
12 
bacterial cells per gram of colonic content, and gut microflora is 
constituted by 400-1,000 species of bacteria.
1,2 Balanced in-
testinal microflora plays a direct impact on maintaining the gut 
homeostasis such as regulating bowel motility, modulating in-
testinal pain, processing nutritional factors and inducing immune 
responses.
3-5 These commensal microbes are recognized by pat-
tern recognition receptors (PRRs), which in turn regulate mu-
cosal innate immunity and inflammatory responses. Among Microbial Recognition by TRLs
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Table. Representative Toll-Like Receptors and Their Specific 
Ligands
TLRs MAMPs
TLR2 Bacterial lipoproteins (eg, Pam3Cys and MALP-2)
Lipoteichoic acid (LTA)
Peptidoglycan (PGN)
Zymosan 
TLR3 double strand RNA (dsRNA) (eg, Poly [I:C])
TLR4 Lipopolysaccharide (LPS)
TLR5 Flagellin 
TLR7, TLR8 Single strand RNA (ssRNA),
Small anti-viral compounds
TLR9 Unmethylated CpG DNA
TLRs, toll-like receptors; MAMPs, microbe-associated molecular patterns; 
Pam3Cys, a synthetic ligand of TLR2; MALP-2, Macrophage-activating 
lipopeptide-2.
PRRs, Toll-like receptors (TLRs) are the first-discovered and 
the most well characterized member of PRRs, and detect mi-
crobe-associated molecular patterns (MAMPs) present in a wide 
range of microorganisms.
6 Here we present the molecular and 
cellular mechanism of TLR-mediated responses and their clinical 
implication in the gastrointestinal tract. Given the fact that the 
gastrointestinal tract of mammalian hosts harbors vast range of 
microorganism and the intestinal epithelial cells constituting the 
intestinal epithelium constantly contact with enteric microflora at 
a front-line of host-microbial communication, this review will be 
mainly focused on microbial recognition in the intestinal epi-
thelial cells.
Physiological Effects of Intestinal
  Microflora on Gut Homeostasis
Imbalanced microbiota in the gut is known to be one of the 
etiological reasons provoking mucosal inflammation such as in-
flammatory bowel disease (IBD).
2,7 Moreover, bacterial flagellin, 
one of many microbial products, was recently described as a dom-
inant antigen in IBD patients.
8 We and others demonstrated that 
immune responses triggered by microbial products are associated 
with intestinal inflammation.
4,8-11 Moreover, the gut microbiota 
is an important environmental factor that affects intestinal mo-
tility, resulting in irritable bowel syndrome (IBS).
12,13 For in-
stance, intestinal microflora elicits both structural and functional 
responses in the sensory and motor apparatus of the gut by in-
creasing the factors mediating neuronal responses in enteric 
neurons.
13,14 Bifidobacterium bifidum and Lactobacillus acidophilus 
are able to promote motility, while Escherichia species can inhibit 
this effect.
3 In contrast, several studies suggest inhibitory effects 
of enteric bacteria on regulating gut motility.
15,16 Moreover, mi-
crobial factors such as short-chain fatty acids, bacterial endotoxin 
or chemotactic peptides (eg, formyl-methionyl-leucyl-phenylala-
nine) released from intestinal bacteria are able to stimulate the en-
teric nervous system in order to affect gut motility.
13,17,18 In this 
context, therefore, disruption of gut microflora is poised to alter 
gut immunity and motility associated with aberrant bowel phy-
siology.
Microbial Recognition by Pattern
  Recognition Receptors
Since living organisms are in a continuous contact with mi-
crobial milieu including commensal and pathogenic microbes, 
the host-microbial communication such as recognizing the pres-
ence of microbes and responding to microbial factors is one of the 
critical measures for innate immunity and commensal relation-
ship between host and microflora. The host-microbial interaction 
is accomplished by a molecular sensor of microbial recognition in 
which microbial sensory system specifically perceives a character-
istic molecular pattern (eg, lipopolysaccharide [LPS], flagellin, 
CpG DNA, single or double strand RNA) from various micro-
organisms. Since the microbial sensory system specifically recog-
nizes and binds to a microbial pattern molecule, the sensory sys-
tem is regarded as PRRs.
6 PRRs recognize microbes in multi- 
cellular organisms, resulting in activating cellular responses ag-
ainst the microorganism: activation of innate and adaptive im-
munity and inflammatory responses.
6
Toll-Like Receptors
TLRs are the type I transmembrane protein, which is com-
posed of leucine rich repeat domain at the extracellular region, 
transmembrane domain and cytoplasmic Toll/IL-1 receptor 
(TIR) domain.
19,20 While leucine rich repeat domain is speci-
alized to recognize a specific microbial ligand, TIR domain is re-
sponsible for mediating the intracellular signaling generated by 
the engagement between TLRs and MAMPs.
21 In human ge-
nome, so far ten TLRs have been identified: TLR1, TLR2, 
TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9 and 
TLR10.
22 TLRs specifically recognize and bind to MAMPs: 
for instance, TLR4 and TLR5 are the receptor for LPS and flag-
ellin, respectively (Table). Based on the cellular localization, Sang Hoon Rhee
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TLRs are categorized into 2 groups: plasma membrane TLRs 
including TLR1, TLR2, TLR4, TLR5 and TLR6 residing in 
the plasma membrane and endosomal TLRs including TLR3, 
TLR7, TLR8 and TLR9 present at intracellular endosomes.
22
TLRs make a homo- or hetero-complex (eg, TLR1/TLR2 
and TLR2/TLR6) to expedite microbial sensing, and recruit an 
array of immediate adaptor molecules to its cytoplasmic TIR do-
main upon a ligand recognition.
21,23 Intensive studies identified at 
least 4 adaptor molecules such as myeloid differentiation primary 
response gene-88 (MyD88), Mal/TIRAP (Mal is also called 
TIR domain-containing adaptor protein [TIRAP]), TIR do-
main-containing adaptor-inducing interferon-β  (TRIF) and 
TRIF-related adaptor molecule (TRAM) interacting with 
TLRs in response to ligand stimulation.
21,24 These adaptor mole-
cules harbor a TIR domain responsible for the interaction with 
the cytoplasmic TIR domain of TLRs. When TLR recognizes a 
microbial ligand, it recruits a single or a combination of adaptor 
molecule(s) to its cytoplasmic TIR domain.
24 Subsequently, these 
adaptor molecules associate with IL-1 receptor-associated kin-
ases (IRAKs) to mediate the signaling to a member of TNF re-
ceptor-associated factor (TRAF) family (eg, TRAF6). Thereby, 
TLR-induced signaling leads to activation of inhibitory κ B kin-
ases (IKKs) and mitogen-activate protein kinases (MAPKs) to 
activate transcription factors such as nuclear factor κ B (NF-κB), 
activator protein-1 (AP-1) and interferon-regulatory factors 
(IRFs), followed by inducing a pleiotropic gene expression in-
volved in immune and inflammatory responses.
22,24,25
Toll-Like Receptors in the Gastrointestinal
  Tract and Their Clinical Relevance
In order to appreciate the impact of enteric microbiota on gut 
physiology, thus, it is very critical to understand how intestinal 
epithelial cells recognize enteric microbiota and what are the con-
sequences resulted from microbial recognition by the intestinal 
epithelial cells. Having found that TLRs are the representative 
microbial recognition sensor at the cell membrane as well as in-
side a cell, TLRs at intestinal epithelial cells should be a key sen-
sory system in recognizing enteric microbes, which in turn alters 
the intracellular signaling within the gut epithelial cells and leads 
to activating innate and inflammatory responses.
Intriguingly, most of intestinal epithelial cell lines are po-
tently responsive to flagellin which is a specific ligand for 
TLR5,
26,27 and hyporesponsive to TLR2 and TLR4 (eg, 
Pam3Cys and LPS, respectively) activation.
28,29 Despite of the 
hypo-responsiveness of TLR4 in various intestinal epithelial 
cells, uncontrolled TLR4 activation is clearly responsible for ne-
crotizing enterocolitis which is a well known pediatric intestinal 
inflammatory disease.
30 Preterm infants show a higher expression 
level of TLR4 at the intestine than normal term infants, which 
renders preterm infants highly susceptible to the intestinal in-
flammation due to TLR4 activation by enteric microbes obtained 
after delivery.
30,31 Moreover, baby formula has been known to 
upregulate TLR4 expression in the intestine, which is probably 
associated with one of the reason for pediatric intestinal 
inflammation.
32 In addition, TLR4 deficiency makes the mouse 
susceptible to dextran sulfate sodium-induced colitis, while feed-
ing LPS to normal mice provides protective effects against dex-
tran sulfate sodium-induced colitis.
33 These studies suggest that 
TLR4 activation by LPS in the intestine may provide beneficial 
effects such as promoting epithelial cell proliferation resulting in 
enhanced wound healing at the intestinal epithelium. Therefore, 
LPS/TLR4 engagement is believed to be one of the most im-
portant factors governing the intestinal physiology.
Given the fact that most intestinal epithelial cells are strongly 
responsive to flagellin,
26,27 TLR5 should be considered as an im-
portant microbial sensor providing a significant impact on in-
testinal epithelial cells which are not only critical for maintaining 
the intact epithelial barrier function, but highly associated with 
the activation of lamina propria cells at the submucosa. Indeed, 
aberrant TLR5 activation appears to be etiologically associated 
with the development and progress of IBD.
4,8 Intriguingly, 
TLR5 seems to be asymmetrically localized at the basolateral side 
of epithelial mucosa.
4,34 Therefore, impaired barrier function of 
the epithelium escalates responsiveness to flagellin, which may be 
responsible for exacerbated intestinal inflammation.
35 Despite 
many studies suggesting that flagellin/TLR5 engagement pro-
motes intestinal inflammation,
4,8,11,36-39 some studies imply that 
flagellin protects mucosal epithelium against mucosal insults (eg, 
radiation).
40,41 Interestingly, Gewirtz’s group reported that 10% 
of TLR5-knockout (KO) mice exhibited spontaneous colitis in a 
TLR4-dependent manner,
42,43 indicating that TLR5 may protect 
from mucosal inflammation. However, they also observed that 
such spontaneous colitis in TLR5-KO mice was not observed in 
“rederived” TLR5-KO mice.
43 Moreover, the other TLR5-KO 
mice independently generated by Flavell’s group have normal 
growth, size, fertility and lifespan, and show no obvious 
abnormalities.
44 Thus, further studies are needed to determine 
whether TLR5 promotes or protects from colitis. In addition to 
the involvement of TLR5 in mucosal inflammation, our recent Microbial Recognition by TRLs
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Figure. Simplified comparison of toll-like receptor (TLR) 4- and 
TLR5-induced signaling pathways. Lipopolysaccharide (LPS) enga-
gement induces the heteromeric complex formation of TLR4, CD14 
and myeloid differentiation protein-2 at the plasma membrane. Then, 
Mal/TIRAP (Mal is also called Toll/IL-1 Receptor [TIR] domain- 
containing adaptor protein [TIRAP]) adaptor is first recruited to the 
cytoplasmic TIR domain of TLR4, followed by recruiting myeloid 
differentiation primary response gene-88 (MYD88) adaptor. Next, it 
activates serine-threonine kinase IL-1 receptor-associated kinases (not 
shown) to recruit TNF receptor-associated factor (TRAF) 6 adaptor. 
TRAF6 relays the signaling to activate inhibitory κ B kinases and 
mitogen-activate protein kinases (MAPKs), resulting in nuclear factor 
κB (NF-κB) and activator protein-1 (AP-1) transcription factor ac-
tivation. In parallel, LPS-stimulated TLR4 complex also recruits TIR 
domain-containing adaptor-inducing interferon-β (TRIF)-related ad-
aptor molecule adaptor to its cytoplasmic region, and the complex is 
internalized to endosome where the complex interacts with TRIF ad-
aptor in order to activate interferon-regulatory factor-3 transcription 
factor activation. In contrast, TLR5 activation by flagellin results in 
recruiting MyD88 adaptor at the plasma membrane, followed by 
activating NF-κB and AP-1 transcription factor. In similar, TLR5 also 
utilizes TRIF at the endosome to activate NF-κB and AP-1 trans-
cription factor. IKKs, inhibitory κ B kinases; IRF-3, interferon-regula-
tory factor-3; MD2, myeloid differentiation protein-2; TRAM, TRIF-
related adaptor molecule.
study showed that TLR5 activation could elicit potent anti-tumor 
immunity against colon cancer by promoting neutrophil infiltra-
tion to tumor legions.
45
TLR3 specifically recognizing double-strand RNA from vi-
ruses elicits potent innate immune responses by inducing IFN-β 
production against rotavirus which is one of well known enteric 
viruses.
46 TLR9 can also be activated in intestinal epithelial cells 
transfected with CpG DNA motifs.
47 Since bacterial DNA har-
bors a large amount of CpG DNA motifs, TLR9 should be acti-
vated by CpG DNA released from enteric bacteria in the intes-
tine.
Toll-Like Receptor-Induced Signaling in the
  Intestinal Epithelial Cells
Although TLR3-, TLR4-, TLR5- and TLR9-induced re-
sponses have been demonstrated in the intestinal epithelial 
cells,
26,27,48-50 among various TLRs are TLR4 and TLR5 which 
have been intensively investigated as it pertains to the gastro-
intestinal diseases. In this review, therefore, TLR-activated mo-
lecular mechanism will be primarily addressed on TLR4- and 
TLR5-mediated responses. TLR4 makes a heteromeric receptor 
complex with CD14 and myeloid differentiation-2 at the plasma 
membrane in order to expedite LPS recognition.
21,23 Mal/ 
TIRAP adaptor molecule is then recruited to the plasma mem-
brane and binds with the cytoplasmic TIR domain of TLR4, fol-
lowed by recruiting MyD88 adaptor molecule. Recruiting 
Mal/TIRAP and MyD88 to TLR4 at the plasma membrane 
leads to activating serine-threonine kinase IRAKs which sub-
sequently interact with TRAF6. TRAF6 is a cytosolic adaptor 
molecule mediating IKKs and MAPKs, which subsequently ac-
tivates transcription factors NF-κB and AP-1, respectively.
51,52 
Meanwhile, LPS binding to the heteromeric complex of TLR4 
also causes additional adaptor recruitment of TRAM. The com-
plex is then endocytosed to endosome in which TRIF adaptor 
molecule is recruited to TLR4 complex. Like Mal/TIRAP for 
MyD88, TRAM adaptor appears to play a bridging role for 
TRIF to be recruited to TLR4.
51,52 Once TRIF is associated 
with TLR4, it primarily induces transcription factor IRF-3 acti-
vation mediating IFN-β production. Collectively, the combina-
tions of Mal/TIRAP-MyD88 and TRAM-TRIF adaptors are 
involved in TLR4-induced signaling pathways, in which the 
former is called the MyD88-dependent pathway mostly asso-
ciated with NF-κB and AP-1 activation, and the latter is the 
MyD88-independent pathway mainly linked to IRF-3 activation 
for anti-viral defense by producing IFN-β (Figure).
TLR5 residing in the plasma membrane has been known to 
utilize only MyD88 adaptor, resulting in activating NF-κB and 
AP-1.
53,54 Our recent study, however, showed that TRIF is re-
cruited to TLR5 at least in the intestinal epithelial cells to regu-
late NF-κB and AP-1 activation, while TRIF associated with 
TLR5 does not appear to elicit IRF-3 activation for IFN-β 
production.
55 Our study also determined that TRAM is not re-Sang Hoon Rhee
32 Journal of Neurogastroenterology and Motility 
cruited to TLR5 upon flagellin stimulation.
55 Upon flagellin 
stimulation, TLR5 seems to be internalized to endosome in 
which TRIF can be attached to TLR5.
56 Based on these studies, 
TLR5 exploits MyD88 and TRIF as adaptors in order to induce 
NF-κB and AP-1 activation regulating pleiotropic expression of 
proinflammatory cytokine gene in response to flagellin. In con-
trast to TLR4 and TLR5, TLR9 is known to use only MyD88 
for NF-κB and AP-1 activation, where TLR3 exclusively uti-
lizes TRIF in order to induce IFN-β expression.
21
Microbial Recognition by Non-pattern
  Recognition Receptors in
  Enterochromaffin Cells
Like intestinal epithelial cells, enterochromaffin (EC) cells 
residing in the mucosa are in a continuous contact with gut mi-
croflora, and communicate with microflora in the gut, and a wide 
variety of receptor expression (eg, 5-hydroxytryptamine [5-HT] 
receptors, pituitary adenylate cyclase-activating polypeptide re-
ceptor, α-adrenergic receptor, β-adrenergic receptor, cholinergic 
receptor, corticotropin-releasing hormone receptor, γ-aminobu-
tyric acid receptor and TLRs) have been suggested in these 
cells.
57,58 EC cells act as mucosal sensory transducers and secrete 
5-HT in response to various physiological and pathological lumi-
nal stimuli. Engagements of these receptors by microbial factors 
or bacterial toxins seem to trigger a delicate mechanism for the 
production of 5-HT in EC cells,
59-61 thereby modulate the gut 
motility. Unfortunately, microbial factors stimulating receptors 
on EC cells and the molecular and cellular mechanisms have yet 
to be studied.
Nonetheless, although microbial recognition is primarily 
mediated by PRRs like TLRs, some bacterial products are able 
to interact with its own specific receptor which is not a member of 
PRRs. For instances, cholera toxin, a secretory enterotoxin from 
Vibrio cholerae, binds to its receptor GM1 ganglioside in EC cells. 
A recent study showed that odorants present in the luminal envi-
ronment stimulate olfactory receptors expressed in EC cells, re-
sulting in 5-HT production.
62
Conclusion
TLRs specifically recognize the presence of microorganisms, 
and there are large numbers of microbes in the gut. Thus, the 
gastrointestinal tract is the primary organ in which microbial rec-
ognition by TLRs should be essential to maintain the home-
ostasis. Indeed, impaired microbial recognition by either altered 
gut microflora or genetic defects of PRRs turned out to be re-
sponsible for certain type of gastrointestinal disease.
2,7 Moreover, 
emerging evidence suggests that microbial recognition in the gut 
elicits potent innate immunity against pathogenic microbes or 
tumors. Therefore, studying TLRs in the gastrointestinal tract is 
now attracting more research interest than any other research 
areas. While numerous studies have been focused on determining 
the complex intracellular signaling pathways and the involvement 
of signaling molecules in TLR-dependent responses, studies on 
clinical relevance of TLRs in the gastrointestinal tract still remain 
unclear. Thus, during the next decade, translational and clinical 
researches on this area will be aimed to determine the disease rele-
vance of TLRs or TLR-dependent signaling pathways, which in 
turn pave the way to develop new therapeutic approaches of the 
gastrointestinal disease including IBD and IBS.
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